Detalhe da pesquisa
1.
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.
Proc Natl Acad Sci U S A
; 119(4)2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064078
2.
Genomic and clinical characterization of stromal infiltration markers in prostate cancer.
Cancer
; 126(7): 1407-1412, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31905251
3.
PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
Oncogene
; 43(1): 22-34, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875657
4.
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation.
Cancer Discov
; 14(3): 424-445, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38197680
5.
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.
Res Sq
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405800
6.
PTEN regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
Res Sq
; 2023 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37292818
7.
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer.
Sci Transl Med
; 15(722): eadf6732, 2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967200
8.
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer.
Nat Cancer
; 4(5): 699-715, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37038004
9.
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer.
Cancer Res Commun
; 3(8): 1447-1459, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37546702
10.
The NOGO receptor NgR2, a novel αVß3 integrin effector, induces neuroendocrine differentiation in prostate cancer.
Sci Rep
; 12(1): 18879, 2022 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344556
11.
Epigenetics in prostate cancer: clinical implications.
Transl Androl Urol
; 10(7): 3104-3116, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430414
12.
Activated ALK Cooperates with N-Myc via Wnt/ß-Catenin Signaling to Induce Neuroendocrine Prostate Cancer.
Cancer Res
; 81(8): 2157-2170, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33637566
13.
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis.
NPJ Precis Oncol
; 5(1): 76, 2021 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34385567
14.
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.
Nat Commun
; 12(1): 6377, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737261
15.
Transcriptional mediators of treatment resistance in lethal prostate cancer.
Nat Med
; 27(3): 426-433, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33664492
16.
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.
Nat Commun
; 12(1): 1979, 2021 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785741
17.
Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma.
Mol Cancer Ther
; 19(1): 147-156, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582532
18.
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
J Clin Invest
; 130(4): 1653-1668, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32091413
19.
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy.
Mol Cancer Ther
; 19(5): 1157-1164, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32127465
20.
Towards precision oncology in advanced prostate cancer.
Nat Rev Urol
; 16(11): 645-654, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591549